Monte Rosa Therapeutics (GLUE) Current Assets: 2023-2025
Historic Current Assets for Monte Rosa Therapeutics (GLUE) over the last 3 years, with Sep 2025 value amounting to $401.8 million.
- Monte Rosa Therapeutics' Current Assets rose 59.95% to $401.8 million in Q3 2025 from the same period last year, while for Sep 2025 it was $401.8 million, marking a year-over-year increase of 59.95%. This contributed to the annual value of $377.4 million for FY2024, which is 59.79% up from last year.
- Per Monte Rosa Therapeutics' latest filing, its Current Assets stood at $401.8 million for Q3 2025, which was up 34.18% from $299.5 million recorded in Q2 2025.
- In the past 5 years, Monte Rosa Therapeutics' Current Assets registered a high of $401.8 million during Q3 2025, and its lowest value of $182.9 million during Q3 2023.
- In the last 3 years, Monte Rosa Therapeutics' Current Assets had a median value of $251.2 million in 2024 and averaged $273.4 million.
- Its Current Assets has fluctuated over the past 5 years, first dropped by 17.26% in 2024, then skyrocketed by 66.94% in 2025.
- Over the past 3 years, Monte Rosa Therapeutics' Current Assets (Quarterly) stood at $236.2 million in 2023, then spiked by 59.79% to $377.4 million in 2024, then soared by 59.95% to $401.8 million in 2025.
- Its Current Assets was $401.8 million in Q3 2025, compared to $299.5 million in Q2 2025 and $332.3 million in Q1 2025.